P-232: Comprehensive genomic sequencing predicts sub-optimal response to bispecific antibodies (BsAb) and chimeric antigen receptor T cells (CAR-T) in multiple myeloma (MM)

Discussant(s)

• 

  Lugui Qiu, MD (he/him/his)

  Department Head
  Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.
  Tianjin , China (People's Republic)

Poster Presenter(s)

• 

  Kylee Maclachlan, MBChB, PhD

  Assistant Attending Physician
  Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA, New York, United States